SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $404,000 | -14.4% | 28,800 | +3.6% | 0.00% | 0.0% |
| Q2 2015 | $472,000 | +56.8% | 27,800 | +11.6% | 0.00% | 0.0% |
| Q1 2015 | $301,000 | +12.3% | 24,900 | -22.9% | 0.00% | – |
| Q4 2014 | $268,000 | -42.5% | 32,300 | -39.7% | 0.00% | -100.0% |
| Q3 2014 | $466,000 | -46.6% | 53,600 | -32.7% | 0.00% | 0.0% |
| Q2 2014 | $873,000 | -15.2% | 79,700 | -30.8% | 0.00% | -50.0% |
| Q1 2014 | $1,029,000 | +29.3% | 115,100 | +9.0% | 0.00% | +100.0% |
| Q4 2013 | $796,000 | +4.5% | 105,600 | +1.5% | 0.00% | -50.0% |
| Q3 2013 | $762,000 | +20.4% | 104,000 | +5.7% | 0.00% | +100.0% |
| Q2 2013 | $633,000 | – | 98,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |